Rapport Therapeutics
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of precision medicines for neurological disorders.

Year Established: 2023
Stock Ticker:
Exchange:
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of precision medicines for neurological disorders.
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of precision medicines for neurological disorders.
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of precision medicines for neurological disorders.